Two Sigma Investments, LP Akero Therapeutics, Inc. Transaction History

Two Sigma Investments, LP

$42.3 Billion
Q3 2024

A detailed history of Two Sigma Investments, LP transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 88,820 shares of AKRO stock, worth $2.84 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

88,820

Previous 120,074 26.03%

Holding current value

$2.84 Million

Previous $2.82 Million 9.52%

% of portfolio

0.01%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$21.45 - $29.34 $670,398 - $916,992	-31,254 Reduced 26.03%	88,820 $2.55 Million
Q2 2024 Aug 14, 2024	BUY	$18.31 - $24.62 $1.39 Million - $1.87 Million	75,787 Added 171.13%	120,074 $2.82 Million
Q1 2024 May 15, 2024	BUY	$17.76 - $31.18 $786,537 - $1.38 Million	44,287 New	44,287 $1.12 Million
Q2 2023 Aug 14, 2023	SELL	$36.89 - $56.88 $7,378 - $11,376	-200 Reduced 0.59%	33,800 $1.58 Million
Q1 2023 May 15, 2023	SELL	$37.27 - $50.24 $310,160 - $418,097	-8,322 Reduced 19.66%	34,000 $1.3 Million
Q4 2022 Feb 14, 2023	SELL	$33.44 - $54.8 $3.05 Million - $5 Million	-91,225 Reduced 68.31%	42,322 $2.32 Million
Q3 2022 Nov 14, 2022	BUY	$10.15 - $34.05 $679,146 - $2.28 Million	66,911 Added 100.41%	133,547 $4.55 Million
Q2 2022 Aug 15, 2022	SELL	$8.0 - $15.01 $83,392 - $156,464	-10,424 Reduced 13.53%	66,636 $630,000
Q1 2022 May 16, 2022	BUY	$12.97 - $22.26 $746,553 - $1.28 Million	57,560 Added 295.18%	77,060 $1.09 Million
Q4 2021 Feb 14, 2022	SELL	$19.87 - $26.24 $1.22 Million - $1.61 Million	-61,471 Reduced 75.92%	19,500 $412,000
Q3 2021 Nov 15, 2021	SELL	$18.65 - $25.46 $1.52 Million - $2.07 Million	-81,446 Reduced 50.15%	80,971 $1.81 Million
Q2 2021 Aug 16, 2021	SELL	$24.81 - $32.35 $727,702 - $948,857	-29,331 Reduced 15.3%	162,417 $17.2 Million
Q1 2021 May 17, 2021	SELL	$24.04 - $34.19 $573,017 - $814,952	-23,836 Reduced 11.06%	191,748 $5.56 Million
Q4 2020 Feb 16, 2021	BUY	$25.12 - $29.89 $3.75 Million - $4.46 Million	149,096 Added 224.24%	215,584 $5.56 Million
Q3 2020 Nov 16, 2020	BUY	$30.79 - $39.92 $1.46 Million - $1.9 Million	47,471 Added 249.62%	66,488 $2.05 Million
Q2 2020 Aug 14, 2020	BUY	$19.25 - $26.76 $366,077 - $508,894	19,017 New	19,017 $474,000

Others Institutions Holding AKRO

# of Institutions

190

Shares Held

73.8M

Call Options Held

241K

Put Options Held

647K

View Full List

About Akero Therapeutics, Inc.

Ticker AKRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,417,600
Market Cap $1.49B
Description
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...

More about AKRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Akero Therapeutics, Inc. Transaction History